Lu Zhen

CEO

19 past transactions

Metaways

Series A in 2025
Metaways provides research, development, designing, and manufacturing solutions for micro OLED display devices and modules.

Fourier Intelligence

Series E in 2025
Fourier Intelligence is a Shanghai-based technology and design company specializing in exoskeleton robotics for rehabilitation and orthotic solutions. The company develops advanced robotic products, including upper-limb rehabilitation devices and lower-limb exoskeletons, aimed at helping individuals with disabilities regain mobility and independence. Its innovations not only assist users in overcoming physical limitations but also enhance productivity by reducing fatigue and enabling the safe transportation of heavy objects in various sectors, particularly healthcare and rehabilitation. Fourier Intelligence's versatile robotic technologies, such as the Humanoid GR-1, are designed to improve efficiency and safety for users, promoting significant advancements in the field of rehabilitation.

RUICYCLE

Series C in 2024
Ruicycle is a high-tech company that focuses on the comprehensive recycling and utilization of lithium batteries.

Super Silicon Semiconductor

Series C in 2024
Super Silicon Semiconductor focuses on the research and development of parts and materials for silicon integrated circuits.

Calterah

Series D in 2024
Calterah specializes in the development of CMOS single-chip millimeter-wave radar sensors aimed at automotive applications. The company produces system-on-chip (SoC) products that integrate radar signal processing baseband technology, facilitating the design and implementation of mmWave radar sensors. These sensors find applications in various sectors, including both industrial and consumer markets, supporting technologies related to environmental sensing, autonomous obstacle avoidance, and radar imaging. Calterah's innovations contribute significantly to advancements in autonomous driving and related technologies.

Systech

Series B in 2024
Systech is an electroplating equipment manufacturing company. It manufactures all electroplating and chemical plating equipments.

Sinovent

Series E in 2024
Sinovent Inc. is a biopharmaceutical company established in 2016, with its headquarters in Suzhou, China, and additional offices in Beijing and Boston. The company focuses on developing innovative treatment methods through its advanced biotechnology platform and extensive management experience. Sinovent aims to address global healthcare challenges by combining expertise in science, management, and finance. Currently, it has 12 products in development, primarily targeting oncology, autoimmune diseases, and infectious diseases.

Triastek

Series C in 2023
Triastek specializes in the development of 3D printed medicines and the associated manufacturing facilities. The company is focused on innovating pharmaceutical 3D printing technology to enhance the design, development, and production of pharmaceutical products. Triastek has created proprietary technology that encompasses the entire process, from pharmaceutical dosage form design to digital development and continuous production. This approach aims to revolutionize drug delivery and manufacturing solutions within the medical industry. Additionally, Triastek has filed patent applications to protect its technological advancements.

Joyintech

Venture Round in 2023
Joyintech is a company that creates asset management software for the financial industry. The company creates business management systems, asset management systems, and securitization systems for banks and other financial institutions, allowing its customers in the financial industry to manage their businesses digitally and efficiently.

GeneMind Biosciences

Series C in 2023
GeneMind Biosciences Company Limited, founded in 2012 and based in Shenzhen, China, specializes in the development and manufacturing of medical devices, particularly focusing on third-generation genome sequencing technology. This advanced technology enables noninvasive detection, disease diagnosis, and personalized treatment options. GeneMind aims to enhance gene sequencing solutions for clinicians and researchers, positioning its gene sequencer as a key asset in the field. The company's commitment to innovation is driven by ongoing research efforts to overcome challenges in gene sequencing, reflecting its dedication to advancing healthcare through improved diagnostic capabilities.

OptoMedic

Debt Financing in 2023
OptoMedic specializes in the research, development, and production of advanced optical medical devices and systems. The company focuses on creating medical fluorescence navigation endoscopes that utilize aerospace and military optical technology for applications in healthcare. Its product offerings include endoscopic monitoring equipment, cancer screening tools, endoscopic navigation systems, and fluorescent imaging systems. These innovations enable medical institutions and healthcare providers to effectively observe and assess patient conditions, enhancing diagnostic capabilities and treatment outcomes.

Xindi Digital Engineering System

Series D in 2023
Xindi Digital Engineering System specializes in the development of 3D CAD software for manufacturing enterprises.

ZStack

Series C in 2023
ZStack is a provider of cloud computing services focused on making cloud technology more accessible for enterprises across various industries, including government, finance, education, and manufacturing. The company offers a range of solutions, including private and hybrid cloud systems, mini hyper-converged machines, and a cloud management platform. Additionally, ZStack provides enterprise-class distributed storage and other cloud-related products, enabling businesses to manage their data center resources—covering computing, networking, and storage—under a unified framework. With a client base of over 2,500 enterprise users, ZStack has also formed partnerships with more than 250 cloud vendors to enhance its ecosystem and channel offerings.

BociMed

Series B in 2023
BociMed is a company engaged in drug research and development and clinical research. Through the establishment of a standardized service system, it provides high-quality R&D and outsourcing services for drug discovery, preclinical pharmaceutical research and development, clinical I-IV trials and registration.Shanghai Bozhiyan New Drug Technology Co., Ltd. is a high-tech enterprise specializing in drug research and development technical services, Shanghai High-tech Enterprise, Shanghai Credit Creation Enterprise, and Shanghai Small and Medium Enterprise Innovation Undertaking Enterprise. The company started in 2007 and was formerly known as Shanghai Maibo Pharmaceutical Technology Co., Ltd., registered in Jinshan Petrochemical Zone, mainly engaged in raw material sales, drug import registration and regional cooperation development in China. In 2012,

Xi'an Triangle Defense

Post in 2023
Xi'an Triangle Defense Co., Ltd. is a research, development, and manufacturing firm based in Xi'an, China, specializing in precision forgings for both military and civilian applications. The company produces a range of products, including airplane structure parts, civil aircraft frames, landing gear, and integral structural components for aero-engines. Additionally, it manufactures engine discs and large to medium-sized die forgings. Xi'an Triangle Defense serves various industries, such as aviation, aerospace, maritime, defense, and nuclear sectors, both domestically and internationally.

BioInno

Series A in 2021
BioInno is a China-based company that specializes in biopharmaceutical contract development and manufacturing organization (CDMO) services. It focuses on process development and Good Manufacturing Practice (GMP) production for biotechnology and pharmaceutical companies seeking to introduce protein, cell therapy, and gene therapy drugs to both the Chinese and global markets. By offering comprehensive outsourcing solutions, BioInno supports clients in the complex development and production processes necessary for bringing innovative therapies to market.

Gerui Liye

Series C in 2021
Gerui Liye is an intelligent manufacturing solution service provider focusing on semiconductors with AI in manufacturing applications.

Yunying Medical

Venture Round in 2020
Yunying Medical specializes in gene mutation, methylation detection, and recombination solutions for cancer diagnosis and treatment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.